BridgeMD
New treatment option for Myocardial Infarction
Official title Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions
ClinicalTrials.gov ID: NCT07617376
What this study is testing
What is Influenza vaccination?
Influenza vaccination is an investigational medicine, being studied as a potential treatment for myocardial infarction.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Patients hospitalized for acute cardiac conditions-including acute myocardial infarction, acute heart failure, pulmonary embolism, arrhythmias, and hypertensive emergencies-represent a heterogeneous population at very high risk of recurrent cardiovascular events. Influenza infection may act as a trigger for adverse cardiovascular events.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Acute cardiac hospitalization,
- Planned discharge home within the next 48 hours following completion of in-hospital treatment,
- No prior influenza vaccination for the current influenza season.
You likely can't join if
- History of a severe adverse reaction to influenza vaccination,
- Allergy to any component of the vaccine to be administered,
- Discharge to another hospital for continuation of treatment or discharge to a long-term care facility,
- Antibiotic therapy to be continued after discharge.
The study team makes the final eligibility decision.
Where it's taking place
- Wroclaw, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wroclaw, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.